Hungary vs Venezuela, Bolivarian Republic of: Treatment success rate for patients treated for MDR-TB
Hungary
79.0%
in 2022
Venezuela, Bolivarian Republic of
78.0%
in 2022
Hungary rank
56th
Venezuela, Bolivarian Republic of rank
59th
Treatment success rate for patients treated for MDR-TB over time
- Hungary
- Venezuela, Bolivarian Republic of
How they compare
Hungary currently reports 79.0% against 78.0% in Venezuela, Bolivarian Republic of, a difference of 1.0%.
The two have swapped places 3 times across 16 shared years of data; in 2006 it was Venezuela, Bolivarian Republic of ahead.
Hungary ranks 56th and Venezuela, Bolivarian Republic of ranks 59th of 163 countries.
Venezuela, Bolivarian Republic of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hungary | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 39.0% | 65.7% | 26.7% | Venezuela, Bolivarian Republic of |
| 2010s | 45.5% | 62.4% | 16.9% | Venezuela, Bolivarian Republic of |
| 2020s | 68.7% | 70.0% | 1.3% | Venezuela, Bolivarian Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Hungary or Venezuela, Bolivarian Republic of?
- Hungary, at 79.0% against 78.0% in Venezuela, Bolivarian Republic of as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Hungary and Venezuela, Bolivarian Republic of?
- 1.0%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Venezuela, Bolivarian Republic of?
- 16 years are reported by both, from 2006 to 2022.
- How do Hungary and Venezuela, Bolivarian Republic of rank globally for treatment success rate for patients treated for mdr-tb?
- Hungary ranks 56th and Venezuela, Bolivarian Republic of ranks 59th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.